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Abstract
Background: Macaques are an excellent model for many human diseases, including reproductive diseases such as
endometriosis. A long-recognized need for early biomarkers of endometriosis has not yet resulted in consensus.
While biomarker studies have examined many bodily fluids and targets, cervicovaginal secretions have been
relatively under-investigated. Extracellular vesicles (EVs, including exosomes and microvesicles) are found in every
biofluid examined, carry cargo including proteins and RNA, and may participate in intercellular signaling. Little is
known about EVs in the cervicovaginal compartment, including the effects of reproductive tract disease on quantity
and quality of EVs.
Case presentation: In September 2014, a 9-year-old rhesus macaque was diagnosed with endometriosis at The
Johns Hopkins University School of Medicine. Ultrasound-guided fine needle aspiration of a cyst and subsequent
laparotomy confirmed diagnosis. The animal was sent to necropsy following euthanasia for humane reasons.
Perimortem vaginal swabs and cervicovaginal lavages were obtained. Using a combination of methods, including
ultracentrifugation and NanoSight visualization technology, approximate numbers of EVs from each sample were
calculated and compared to populations of EVs from other, reproductively normal macaques. Fewer EVs were
recovered from the endometriosis samples as compared with those from reproductively healthy individuals.
Conclusion: To our knowledge, this is the first examination of EVs in primate cervicovaginal secretions, including
those of a macaque with endometriosis. This case study suggests that additional research is justified to determine
whether quantification of EVs—or their molecular cargo—in cervicovaginal lavage and vaginal swabs may provide
a novel, relatively non-invasive diagnostic for primate endometrial disease or other reproductive tract diseases.
Background
Endometriosis is a benign but debilitating disease of
humans and other primates that affects the reproductive
tract and has a reported incidence rate of up to 10 % in
females of reproductive age [1]. Generally, the term
endometriosis is used to describe the condition in which
endometrial cells (glands or stroma) develop ectopically,
or outside of the uterine cavity [2]. Symptoms of endo-
metriosis include chromic abdominal and pelvic pain,
dysmenorrhea, as well as subfertility and likely eventual
infertility [3, 4]. Treatment protocols have not been stan-
dardized, but typically include surgical removal of ec-
topic tissue as well as removal of associated adhesions.
The current gold standard for diagnosis of the dis-
ease combines laparoscopic evaluation and biopsy. In
humans, endometriosis is thought to be prevalent for
an average 8 to 11 years before diagnosis [5] and mul-
tiple years after the appearance of symptoms [6, 7].
Earlier detection would likely make surgical treatment
more effective, afford individuals affected by the dis-
ease more options for treatment, and assist in the
search for factors involved in pathogenesis. Indeed,
the urgent need for early diagnosis was recognized
well over a half-century ago [8].
Despite a burgeoning literature on the topic, as yet
there is no consensus on early, non-invasive diagnosis
methods. Diagnostic markers have been sought in
peritoneal, follicular, and endometrial fluid, in urine,
and in blood cells and cell-free fractions (see reviews
[6, 7, 9–12]). Employment of ultrasound, MRI [13, 14]
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and measurement of electrical resistance of dermal-
visceral zones [15] have also been studied. Recently,
attention has turned to circulating miRNAs, which
have been reported as biomarkers of various diseases
[16]. At least three published studies [17–19] have found
an association between endometriosis and differential
regulation of specific miRNAs in circulation, although
caution in interpretation has been urged due to estrogen
sensitivity of some miRNAs [20]. Remarkably, there is no
overlap of miRNA biomarkers reported in the different
studies. Indeed, one of the studies reported differential
expression of miR-16, which was elsewhere used as an
invariant control. The lack of concordance between circu-
lating miRNA biomarker studies has previously been
reported for conditions including breast cancer [21, 22],
and may be due to the high non-specific background of
miRNAs that are not associated with disease or are associ-
ated with many conditions [23]. Since miRNAs are pro-
tected in biofluids by various molecular carriers [24, 25], it
may be possible to achieve greater discrimination by focus-
ing on extracellular particles, such as extracellular vesicles
(EVs) that may be specifically released from cells [22].
EVs are lipid bilayer vesicles [26] that carry a varied
cargo including nucleic acids, proteins, metabolites, and
lipids. Release of EVs is thought to have a variety of func-
tions, including disposal of harmful cellular contents and
transmission of regulatory molecules in a form of intercel-
lular communication. While determining levels of specific
EV cargoes such as miRNAs may be useful in diagnosis,
an initial study might yield results with even simpler mea-
surements such as EV particle or EV protein concentra-
tion. Indeed, such measurements have previously achieved
reported success in ovarian cancer [27].
We hypothesized that a promising potential avenue for
achieving early diagnosis of reproductive tract diseases in-
cluding endometriosis might involve examination of total
extracellular particles and EVs in cervicovaginal secre-
tions. In this report, we examined particle concentration
in total extracellular particle and EV-enriched ultracentri-
fuged fractions from cervicovaginal swabs (CVS) and
cervicovaginal lavage (CVL) from an individual with endo-
metriosis. We compared these data with results obtained
from reproductively normal nonhuman primates, observ-
ing apparent disease-associated differences in particle con-
centrations. To our knowledge, this is the first report of
extracellular particle and EV-enriched particle fractions in
cervicovaginal secretions from any species.
Case presentation
A 9-year-old female rhesus macaque (Macaca mulatta)
with a history of a previous caesarian section presented
with a large, firm uterine mass on abdominal and rectal
palpation at routine semi-annual physical exam. All
animal studies were approved by the Johns Hopkins
University Institutional Animal Care and Use Commit-
tee and conducted in accordance with the Weatherall
Report, the Guide for the Care and Use of Laboratory
Animals, and the USDA Animal Welfare Act. Abdom-
inal ultrasound revealed numerous cysts near the
uterus. Fine needle aspirate of one of the cysts revealed
dark red-brown fluid that on cytology contained nu-
merous degenerate red blood cells, foamy macrophages
with hemosiderin, scattered neutrophils and lympho-
cytes as well as numerous clusters of endometrial-like
cells (chocolate cyst) (Fig. 1). A laparotomy was subse-
quently performed, which revealed extensive cyst for-
mation localized to the ovaries; numerous adhesions
extending from and between the reproductive tract and
the bladder and omentum were observed. Euthanasia
was elected due to poor prognosis.
Pathologic findings
On necropsy, the animal was in good postmortem con-
dition and good body condition (BCS 3/5). The uterus
was markedly thickened and nodular with a prominent
“chocolate brown” cystic structures on the serosal ven-
tral surface. Dissection between the uterus body, uter-
ine horns, and ovaries was not possible due to the
extensive adhesions (Fig. 2). One ovary was grossly dis-
cernable and exhibited multiple simple cysts as well as
a cyst containing “chocolate brown” material.
Ovarian histology confirmed initial examination im-
pressions of endometriosis: Transmurally disrupting and
expanding the parenchyma of the bladder and uterus
and also impacting the mesentery of the retroperitoneal
space were multiple, unencapsulated, infiltrative islands
of ectopic endometrial glands surrounded by densely cel-
lular endometrial stromal tissue. The endometrial glands
were lined by simple columnar epithelial cells with a mod-
erate amount of clear to pale eosinophilic cytoplasm. The
endometrial stroma was composed of spindle cells with
indistinct cell borders, scant eosinophilic cytoplasm and
an oval nucleus with finely stippled chromatin. Occasion-
ally glands contained moderate numbers of macrophages,
neutrophils, erythrocytes, and cellular debris. Within the
retroperitoneal mesenteric adipose tissue, multifocal areas
of hemorrhage, degenerate neutrophils, and necrotic deb-
ris is appreciated along with plump mature reactive fibro-
blasts (adhesions). The adjacent lymph node contained
increased number of histiocytes, which often demon-
strated erythrophagocytosis along with hemorrhage and
congestion (Fig. 3).
Assessment of extracellular particles in secretions
Just prior to euthanasia, CVS and CVL were collected.
Samples were collected with the aid of a vaginal speculum
by either gently swabbing in the endocervical area with a
sterile cottom swab or by lavaging the vaginal vault with a
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syringe filled with 3.0 mililiters of 1X PBS, respectively.
The total yield of CVL fluid was recorded. Swabs were im-
mediately placed in two mL of 1X Dulbecco’s PBS and
within thirty minutes of collection were swirled in a circu-
lar fashion within the PBS and then repeatedly pressed
against the side of their respective 15 mililiter conicals to
ensure optimal liberation of secretions; lavage fluid was
collected into a 15 mililiter conical. Normal CVL samples
were pooled by species prior to analysis. Both types of
samples were centrifuged at 1,000xg for 15 min to remove
cells and large debris. Following this first spin, supernatant
from each of the sample types was saved, diluted 1:10 with
Fig. 1 Cytology of fine needle aspirate obtained from abdominal mass. Characteristic hemosiderin-laden macrophages are noted along with a tight
cluster of cells with dense, large nuclei and minimal cytoplasm, consistent with endometrial-like cells on a moderate background of erythrocytes.
Diff-Quick stain (40X)
Fig. 2 Abdominal Mass. Multiple, large cystic and blood-filled nodules were present in the abdominal cavity along with numerous fibrous
adhesions (arrows)
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1X phosphate buffered saline (PBS) and subjected to sin-
gle particle tracking with a NanoSight NS-5001 system. At
least five 20-s videos were recorded of each sample at a
camera setting of 14, and files were analyzed at a detection
threshold of ten using NanoSight software version 2.2.
Samples subsequently underwent high-speed ultracen-
trifugation (110,000xg for 70 min at 4 °C) using a Sorvall
Discovery 100SE2 instrument and a Sorvall AH-6502
swinging-bucket rotor (k-factor =53). After carefully
pouring off supernatant, pellets were resuspended in 500
ul PBS using an optimized resuspension protocol. Both
sets of samples were diluted at a ratio of 1:10 as well and
observed using the same camera and detection threshold
settings as were used for the pre-ultracentrifugation obser-
vation (described above).
Particle counts of samples from the endometriosis case
were compared with CVL and CVS data obtained from
four other individuals (two rhesus macaques and two
pigtailed macaques, Macaca nemestrina) that had no
notable reproductive tract history or pathology at nec-
ropsy, using the same protocols. Histologic examination
of endometrial tissue from the 4 reproductively normal
animals revealed that the animals were either in the pro-
liferative phase (n = 3) or early secretory (n = 1) phase of
the menstrual cycle, allowing for the best physiologic
comparison with respect to the presence of endometrial
cells observed in endometriosis [28–30].
Results
After removal of cells and large debris from the CVS
fluid by low-speed centrifugation, on average approxi-
mately 30-fold fewer extracellular particles were found
in the endometriosis sample than in samples from repro-
ductively healthy rhesus and pigtailed macaques (Fig. 4a).
In corresponding CVL samples, similar but less pro-
nounced differences were obtained (Fig. 4b).
Stepped ultracentrifugation is the most widely used
and accepted method for EV enrichment [31], although
other particles may co-purify with EVs [31–35]. Follow-
ing a standard ultracentrifugation protocol, the resulting
EV-enriched particle population was approximately
nine- to 13-fold more abundant in CVS samples from
reproductively healthy animals than in the case of endo-
metriosis (Fig. 4c), and approximately ten- to 20-fold
more abundant in corresponding CVL (Fig. 4d).
Conclusions
Here, we report nanoparticle tracking analysis of extra-
cellular particles including EVs in cervicovaginal samples
associated with a verified case of an ongoing endometrial
disease process. In samples collected by both lavage and
swab, particle concentration was markedly decreased in
the case of endometriosis as compared with reproduc-
tively healthy animals.
In this case report, we are admittedly unable to ad-
dress several important issues. First, since results were
obtained after the disease had taken its full course, it is
unclear whether particle counts would be altered in early
stage disease. Carefully designed longitudinal studies of
primate endometriosis models will be needed. Second,
our studies focused on quantifying particles using the
limited volume of sample we could obtain from the case,
to the exclusion of other techniques that might have
provided more information on the subtypes (“exosomes,”
“microvesicles,” etc.), origins, and potential functions of
particles. We chose NTA as one of the first and simplest
readings that could be done, one that would thus be po-
tentially useful in the clinic. However, many biological
Fig. 3 Abdominal Wall. Numerous poorly organized and ectacic endometrial glands were haphazardly arranged within dense connective tissue.
H&E stain (10X)
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questions remain unanswered. EM and immunoaffinity
assays, likely using pooled samples, will be needed to
identify the various sources and types of particles found
in the cervicovaginal compartment—sources, we would
note, that might include the microbiome, not just the
host. Third, we do not know what is causing the ob-
served decrease. The mechanisms for altered EV and
other particle release from the endometrium and the
vaginal epithelium—in disease or during cycling or preg-
nancy—must be identified through longitudinal sam-
pling (as mentioned above) of different compartments.
For example, to ascertain the effects of normal or altered
cycling, one might wish to examine particle populations
in paired vaginal and intrauterine swabs along with hor-
mone levels to [36]. Finally, we have not yet profiled
cervicovaginal particles for amplifiable biomarkers, such
as RNA molecules.
Although much more remains to be learned about
the nature and functions of the particles and vesicles
we found, our findings suggest that particulates in the
cervicovaginal compartment may provide novel, min-
imally invasive diagnostic tools for reproductive tract
disease. We trust that these results will spur larger
studies in animal models of endometriosis as well as in
human cohorts.
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Fig. 4 Pooled Data from Cervico-Vaginal Swabs and Cervico-Vaginal Lavage. NTA demonstrated a drop in particles per milliliter in pooled
samples from two rhesus macaques (Rh) and two pig-tailed (Pt) macaques as compared to the number of particles observed in the animal
with endometriosis. a and b compare CVS and CVL particles per milliliter at low-speed centrifugation (PRE UC) and c and d compare particles
observed post-ultracentrifugation (POST UC). Asterisk in panel b: a software malfunction resulted in incomplete acquisition of data and loss of
sample. Error bars for averages in CVS samples indicate standard deviation of readings across multiple animals and deviation between readings
for the case endometriosis and CVL pooled samples
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